Results 241 to 250 of about 1,020,663 (289)
Some of the next articles are maybe not open access.

Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.

Radiographics, 2020
Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with neuroendocrine differentiation that show characteristic clinical, histomorphologic, and prognostic features; genetic alterations; and biologic behavior.
L. Khanna   +8 more
semanticscholar   +1 more source

Genetics of Pancreatic Neoplasms and Role of Screening.

Magnetic Resonance Imaging Clinics of North America, 2018
There is a wide spectrum of pancreatic neoplasms with characteristic genetic abnormalities, tumor pathways, and histopathology that primarily determine tumor biology, treatment response, and prognosis. Although most pancreatic tumors are sporadic, 10% of
V. Katabathina   +4 more
semanticscholar   +1 more source

Surveillance of Pancreatic Cystic Neoplasms

Gastrointestinal Endoscopy Clinics of North America, 2023
Pancreatic cystic neoplasms (PCNs) are increasingly detected because of the widespread use of cross-sectional imaging and overall aging population. While the majority of these cysts are benign, some can progress to advanced neoplasia (defined as high-grade dysplasia and invasive cancer).
Ankit, Chhoda   +2 more
openaire   +2 more sources

Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study

Endoscopy, 2019
Background Pancreatic neuroendocrine tumors (NETs) and intraductal pancreatic mucinous neoplasia (IPMN) with worrisome features are surgically managed. Endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) has recently been developed.
M. Barthet   +8 more
semanticscholar   +1 more source

SCHWANNOMA: A RARE PANCREATIC NEOPLASM

Journal of Investigative Medicine, 2005
Background Pancreatic schwannomas are rare neoplasms, which typically affect the adult population. The size of these tumors is highly variable. Since two thirds of these tumors are partially cystic, they grossly mimic cystadenomas and cystadenocarcinomas of the pancreas. The most common presenting symptom is abdominal pain.
T.D. Bui   +3 more
openaire   +1 more source

Epidemiology of Neuroendocrine Neoplasms in the US

JAMA Network Open
Key Points Question What are the epidemiologies of neuroendocrine neoplasms (NEN) in US? Findings In this cross-sectional study evaluating 145 477 NEN cases in the US, age-adjusted incidence rates increased 5.2-fold between 1975 and 2021, with an annual ...
A. Dasari   +7 more
semanticscholar   +1 more source

Laparoscopic enucleation of pancreatic neoplasm

Surgical Endoscopy, 2010
Enucleation is an alternative procedure for treating benign and borderline neoplasms of the pancreas, which preserves healthy parenchyma and pancreatic function. This study aimed to evaluate the postoperative and long-term results after laparoscopic enucleation.Data collected prospectively from 23 consecutive patients who underwent laparoscopic ...
A, Dedieu   +4 more
openaire   +2 more sources

Molecular Characterization of Pancreatic Neoplasms

Advances in Anatomic Pathology, 2008
Molecular analyses of neoplasms of the pancreas, coupled with careful histopathologic examination has helped refine the classification of pancreatic neoplasia. A number of molecularly and histologically distinct subtypes of pancreatic neoplasms have been identified and, importantly, many of these subtypes have important clinical implications.
Chanjuan, Shi   +2 more
openaire   +2 more sources

Pancreatic Neoplasms

Abstract Pancreatic ductal adenocarcinoma (PDAC), sometimes referred to as pancreatic cancer, is a leading cause of cancer death in the US. In 2021 in the US, an estimated 60,430 new cases of PDAC occurred, and 48,220 people died of the disease.
Jaime De La Fuente, Shounak Majumder
openaire   +1 more source

Middle pancreatectomy for pancreatic neoplasms

Journal of Hepato-Biliary-Pancreatic Sciences, 2009
AbstractBackgroundA middle pancreatectomy (MP) is a parenchyma‐preserving procedure for benign or low‐malignant neoplasms in the neck or body of the pancreas that reduces long‐term endocrine and exocrine insufficiency. MP requires the handling of 2 (distal and proximal) pancreatic remnants, and therefore, the higher rates of pancreatic fistula and ...
Seiko, Hirono, Hiroki, Yamaue
openaire   +2 more sources

Home - About - Disclaimer - Privacy